🧮 KROS Operating Income Breakdown
Understanding Operating Income
Operating Income, also known as EBIT (Earnings Before Interest and Taxes), measures a company's profit from its core business operations before financing costs and taxes. For KROS, the trailing twelve month operating income is $10.8M.
Why Operating Income Matters
Operating income isolates business performance from capital structure decisions (debt vs equity financing) and tax strategies. This makes it ideal for comparing companies with different debt levels or tax situations. It shows how efficiently management runs the core operations.
KROS's operating income growth rate of N/A (based on log-linear regression of 0 quarters) indicates relatively flat or slightly declining operational performance.
Operating Income vs Other Profitability Metrics
Net Income: $34.6M →
The bottom line after interest and taxes. Net income shows the final profit, while operating income excludes financing decisions.
Free Cash Flow: $-58.3M →
Actual cash generated after capital expenditures. FCF can differ significantly from operating income due to working capital and capex.
Owner Earnings: $-57.9M →
Buffett's measure of true cash generation. Adds back depreciation and subtracts only maintenance capex.
Revenue: $14.9M →
The top line that operating income is derived from. Operating margin shows what percentage becomes operational profit.
Operating Margin Analysis
KROS's operating margin of 72.32% shows what percentage of revenue converts to operating profit after all operating expenses. Operating margins above 25% are excellent and indicate strong pricing power or operational efficiency.
EV/Operating Income Valuation
The EV/Operating Income ratio of -2.5x shows how the market values KROS's operational earnings. Ratios below 8x often indicate undervaluation or market concerns about future growth.
Summary: KROS Operating Income Trend
KEROS THERAPEUTICS, INC. (KROS) has an operating margin of 72.32%, which Zyberno classifies as excellent for a Healthcare company — above the 20% threshold Zyberno applies to healthcare businesses where R&D spending and regulatory costs weigh on operating margins, signaling significant pricing power and operational efficiency. Operating income grew at N/A annually — a negative trend — revenue erosion that warrants monitoring. For complete financial analysis, view the full KROS stock report on Zyberno.
Frequently Asked Questions
What is KROS's current operating income?
KEROS THERAPEUTICS, INC.'s TTM operating income is $10.8M, growing at N/A annually — a negative trend — revenue erosion that warrants monitoring.
Is KROS's operating income growing?
KEROS THERAPEUTICS, INC. (KROS) has an operating margin of 72.32%, which Zyberno classifies as excellent for a Healthcare company — above the 20% threshold Zyberno applies to healthcare businesses where R&D spending and regulatory costs weigh on operating margins, signaling significant pricing power and operational efficiency. Operating income grew at N/A annually — a negative trend — revenue erosion that warrants monitoring.
What is KROS's operating margin?
KEROS THERAPEUTICS, INC. (KROS) has an operating margin of 72.32%, which Zyberno classifies as excellent for a Healthcare company — above the 20% threshold Zyberno applies to healthcare businesses where R&D spending and regulatory costs weigh on operating margins, signaling significant pricing power and operational efficiency. Operating income grew at N/A annually — a negative trend — revenue erosion that warrants monitoring.
What is the difference between operating income and EBIT?
Operating income and EBIT (Earnings Before Interest and Taxes) are generally the same metric - both measure profit from core operations before financing costs and taxes. KROS's EBIT/Operating Income is $10.8M.
How does operating income differ from net income?
Operating income excludes interest expense and income taxes, while net income includes them. KROS's operating income is $10.8M versus net income of $34.6M. The difference reflects financing costs and tax burden.
📊 Full KROS Stock Report →
See KROS's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 KROS Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 KROS Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 KROS Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 KROS Earnings Surprise (SUE) →
See whether KROS is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 KROS Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 KROS Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 KROS Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 KROS Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.